TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19233003

Group type: EXPERIMENTAL
Intervention: 7.5 mL of 3.5% lidocaine dissolved in fibrin glue (Group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 7.5 mL of lidocaine alone (Group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 7.5 mL of fibrin glue alone (Group C)
Number of subjects: 30
Study: 16824157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1052
Study: 12778099

Group type: EXPERIMENTAL
Intervention: Whole mouth taste test and spatial taste test in postmenopausal women
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Subjective assessment of taste alteration in postmenopausal women
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Alteration in dietary habits after menopause
Number of subjects: 20
Study: 10933266

Group type: EXPERIMENTAL
Intervention: Familial cattle ownership
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Living more than 2 hours away from a water source
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Facial cleanliness at both time points
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Having a clean face at both time points in non-cattle-herding families
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Living more than 2 hours away from a water source in cattle-herding families
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Severe inflammatory trachoma at baseline
Number of subjects: 176
Study: 9330125

Group type: EXPERIMENTAL
Intervention: Carvedilol (up to 25 mg twice daily, n = 70)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo (n = 35)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 8399552

Group type: EXPERIMENTAL
Intervention: T‐set (new connector device for CAPD); 27‐cm extension line filled with Amuchina during dwell time.
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (CG) using a long branch or short branch Y‐set.
Number of subjects: 122
Study: 3094957

Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acetaminophen with codeine
Number of subjects: 40
Study: 29239515

Group type: EXPERIMENTAL
Intervention: Pre-discharge initiation of sacubitril/valsartan (initiated ≥24 hours after hemodynamic stabilization)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Post-discharge initiation of sacubitril/valsartan (initiated within Days 1-14 after discharge)
Number of subjects: 1000
Study: 27483525

Group type: EXPERIMENTAL
Intervention: CHARLY (computer‐aided training platform with a biofeedback interface)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: CHARLY
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (routine training)
Number of subjects: 67
Study: 24961394

Group type: EXPERIMENTAL
Intervention: Diet high in n-3 fatty acids and polyphenols
Number of subjects: 78

Group type: COMPARATOR
Intervention: Other isoenergetic diets differing in n-3 FA and polyphenol content
Number of subjects: 78
Study: 22207700

Group type: EXPERIMENTAL
Intervention: Animated symbols
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Animated verbs
Number of subjects: 52

Group type: COMPARATOR
Intervention: Static verbs
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Animated prepositions
Number of subjects: 52

Group type: COMPARATOR
Intervention: Static prepositions
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Verbs
Number of subjects: 52

Group type: COMPARATOR
Intervention: Prepositions
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Older children
Number of subjects: 52

Group type: COMPARATOR
Intervention: Younger children
Number of subjects: 52
Study: 21091415

Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise program (3 months, starting at 16-20 weeks of gestation)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual activities (control group)
Number of subjects: 64
Study: 19231908

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 1991

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 1991

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1991
Study: 16238893

Group type: EXPERIMENTAL
Intervention: Voriconazole
Number of subjects: 3

Group type: COMPARATOR
Intervention: Conventional amphotericin B
Number of subjects: 3

Group type: COMPARATOR
Intervention: Itraconazole
Number of subjects: 3

Group type: COMPARATOR
Intervention: Voriconazole vs Conventional amphotericin B
Number of subjects: 3

Group type: COMPARATOR
Intervention: Voriconazole vs Itraconazole
Number of subjects: 3
Study: 12885812

Group type: EXPERIMENTAL
Intervention: Paclitaxel 100 mg/m2 weekly for 3 of 4 weeks with carboplatin (AUC = 6)
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Paclitaxel 100 mg/m2 and carboplatin (AUC = 2) weekly for 3 of 4 weeks
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Paclitaxel 150 mg/m2 cycle 1 and 100 mg/m2 cycle 2 and carboplatin (AUC = 2) weekly for 6 of 8 weeks
Number of subjects: 401

Group type: COMPARATOR
Intervention: Weekly paclitaxel therapy (70 mg/m2, 3 of 4 weeks)
Number of subjects: 401

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 401
Study: 10553410

Group type: EXPERIMENTAL
Intervention: Regimen A (CDDP 16 mg/m2 for 5 days, 5-FU 600 mg/m2/day for 120 hours)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Regimen B (CDDP 80 mg/m2 on day 1, 5-FU 600 mg/m2/day for 120 hours)
Number of subjects: 27
Study: 8897078

Group type: EXPERIMENTAL
Intervention: 95 mg metoprolol and 40 mg pantoprazole (test)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 95 mg metoprolol and placebo (reference)
Number of subjects: 18
Study: 1796419

Group type: EXPERIMENTAL
Intervention: Monoclate
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Hemofil-M
Number of subjects: 23
Study: 6391981

Group type: EXPERIMENTAL
Intervention: Fasting alone
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Nasogastric suction
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Fasting plus cimetidine
Number of subjects: 88
Study: 31434775

Group type: EXPERIMENTAL
Intervention: German Unidimensional Self‐Efficacy Scale for Multiple Sclerosis (USE‐MS-G)
Number of subjects: 322
Study: 29609017

Group type: EXPERIMENTAL
Intervention: Calcium-containing gummies
Number of subjects: 44

Group type: COMPARATOR
Intervention: No gummies
Number of subjects: 44

Group type: COMPARATOR
Intervention: Calcium-containing gummies and No gummies
Number of subjects: 44
Study: 26077874

Group type: EXPERIMENTAL
Intervention: DHA supplementation (500 mg) with iron tablet
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo with iron tablet
Number of subjects: 76
Study: 25375279

Group type: EXPERIMENTAL
Intervention: Continuous Exercise (CE: 45 minutes at 65‐70% of heart rate reserve)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Interval Exercise (IE: 5 x 3 minute intervals at 80‐85% HRR with two minutes of active recovery at 65‐70% HRR)
Number of subjects: 16
Study: 22050051

Group type: EXPERIMENTAL
Intervention: DU-125530
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 50
Study: 20505197

Group type: EXPERIMENTAL
Intervention: Posterior lamellar tarsal rotation surgery
Number of subjects: 356
Study: 17607430

Group type: EXPERIMENTAL
Intervention: Multivoxel spectroscopy with short echo time (TE)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Normal cerebral parenchyma
Number of subjects: 31
Study: 16109986

Group type: EXPERIMENTAL
Intervention: Two-implant overdentures (IOD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional dentures (CD)
Number of subjects: 60
Study: 12615557

Group type: EXPERIMENTAL
Intervention: Prophylactic filter placement
Number of subjects: 400
Study: 10709119

Group type: EXPERIMENTAL
Intervention: r‐HuEPO 400 units/kg every alternate day for 10 doses
Number of subjects: 42

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: r‐HuEPO
Number of subjects: 42
Study: 7745512

Group type: EXPERIMENTAL
Intervention: Synthetic surfactant (Exosurf Neonatal)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 89
Study: 2183056

Group type: EXPERIMENTAL
Intervention: Tetrahydroaminoacridine (THA) 100 mg per day
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 7403018

Group type: EXPERIMENTAL
Intervention: Semiannual individual advice and health education campaign
Number of subjects: 19390

Group type: COMPARATOR
Intervention: Control group (baseline examination)
Number of subjects: 19390

Group type: EXPERIMENTAL
Intervention: Random sample of intervention group
Number of subjects: 19390

Group type: COMPARATOR
Intervention: Random sample of control group
Number of subjects: 19390

Group type: EXPERIMENTAL
Intervention: High-risk subjects of intervention group
Number of subjects: 19390

Group type: COMPARATOR
Intervention: High-risk subjects of control group
Number of subjects: 19390
Study: 31425453

Group type: EXPERIMENTAL
Intervention: Low-pressure pneumoperitoneum (LPPLC, 7 mm Hg)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Normal pressure pneumoperitoneum (NPPLC, 14 mm Hg)
Number of subjects: 82
Study: 31060571

Group type: EXPERIMENTAL
Intervention: Health services provided in municipalities
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Health services related to housing, economy, exercise, and social network
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Satisfaction with practical help
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Satisfaction with personnel
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Overall satisfaction
Number of subjects: 491
Study: 28558384

Group type: EXPERIMENTAL
Intervention: 10 mg/kg intravenous paracetamol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 15 mg/kg intravenous paracetamol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 20 mg/kg intravenous paracetamol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol (all doses combined)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral sucrose (control group)
Number of subjects: 60
Study: 26075931

Group type: EXPERIMENTAL
Intervention: LESS-TLH
Number of subjects: 76

Group type: COMPARATOR
Intervention: LESS-LAVH
Number of subjects: 76
Study: 24617224

Group type: EXPERIMENTAL
Intervention: CT virtual endoscopy and pathological check
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional colonoscopy and pathological check
Number of subjects: 80
Study: 20875216

Group type: EXPERIMENTAL
Intervention: Flaxseed oil (FXCO)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High-oleic rapeseed oil (HOCO)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Western diet (WD)
Number of subjects: 36
Study: 19134454

Group type: EXPERIMENTAL
Intervention: Herbs for calming liver and suppressing liver-yang
Number of subjects: 32

Group type: COMPARATOR
Intervention: Flunarizine Capsules
Number of subjects: 32
Study: 16702322

Group type: EXPERIMENTAL
Intervention: High flavanol cocoa (326 mg/d)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Low flavanol cocoa (27 mg/d)
Number of subjects: 2
Study: 15378354

Group type: EXPERIMENTAL
Intervention: Orlistat (120 mg tid) with conventional treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (conventional treatment alone)
Number of subjects: 22
Study: 12575970

Group type: EXPERIMENTAL
Intervention: Captopril (225 mg/day) before treatment
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Captopril (225 mg/day) after treatment
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline infusion (0.154 mol/l at 8 ml/kg/h for 4 h) before captopril
Number of subjects: 8
Study: 9605680

Group type: EXPERIMENTAL
Intervention: Epidural 0.5% bupivacaine followed by 0.25% bupivacaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (unwarmed)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 8583674

Group type: EXPERIMENTAL
Intervention: Portex catheter (Group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Arrow catheter (Group B)
Number of subjects: 20
Study: 2677058

Group type: EXPERIMENTAL
Intervention: Coronal Scaling (CS)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Root Planning (RP)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Modified Widman Surgery (MW)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Flap with Osseous Resectional Surgery (FO)
Number of subjects: 75
Study: 629218

Group type: EXPERIMENTAL
Intervention: Calcium supplementation of 300 mg administered daily from the 20th week of gestation until term
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Calcium supplementation of 600 mg administered daily from the 20th week of gestation until term
Number of subjects: 87

Group type: COMPARATOR
Intervention: Unsupplemented mothers
Number of subjects: 87
Study: 30703137

Group type: EXPERIMENTAL
Intervention: Native language condition
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Switching language condition
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Second language condition
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Low English proficiency
Number of subjects: 500

Group type: COMPARATOR
Intervention: All groups (native, switching, second language)
Number of subjects: 500
Study: 27878951

Group type: EXPERIMENTAL
Intervention: Video-feedback intervention for positive parenting and learning difficulties (VIPP-LD)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 85
Study: 25675061

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (5 mcg) with 3 mL of 0.5% hyperbaric bupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Midazolam (1 mg) with 3 mL of 0.5% hyperbaric bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (0.5 mL of 0.9% saline) with 3 mL of 0.5% hyperbaric bupivacaine
Number of subjects: 60
Study: 24098631

Group type: EXPERIMENTAL
Intervention: Interactive rhythmic cue
Number of subjects: 32

Group type: COMPARATOR
Intervention: Fixed tempo cue
Number of subjects: 32

Group type: COMPARATOR
Intervention: 1/f fluctuating tempo cue
Number of subjects: 32

Group type: COMPARATOR
Intervention: No cue
Number of subjects: 32
Study: 21843846

Group type: EXPERIMENTAL
Intervention: Monitoring by phone and home visits using checklists
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Telephone monitoring
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Home visits
Number of subjects: 97
Study: 19675462

Group type: EXPERIMENTAL
Intervention: Low‐addition silicone hydrogel multifocal soft lens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monovision
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multifocal correction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Habitual correction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Optimized distance visual correction
Number of subjects: 0
Study: 17920506

Group type: EXPERIMENTAL
Intervention: LED curing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Halogen light curing
Number of subjects: 30
Study: 15477437

Group type: EXPERIMENTAL
Intervention: Topical diclofenac solution
Number of subjects: 326

Group type: COMPARATOR
Intervention: Vehicle-control solution
Number of subjects: 326
Study: 11252296

Group type: EXPERIMENTAL
Intervention: Endoscopic ventricular catheter placement
Number of subjects: 77

Group type: COMPARATOR
Intervention: Conventional ventricular catheter placement
Number of subjects: 77

Group type: COMPARATOR
Intervention: Comparison of endoscopic vs conventional placement
Number of subjects: 77
Study: 9990211

Group type: EXPERIMENTAL
Intervention: Patient-controlled sedation (PCS) with propofol (bolus: 0.2 mg.kg‐1, lockout time: 3 min)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Anesthesiologist-controlled sedation (ACS) with propofol (continuous infusion)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both PCS and ACS
Number of subjects: 11
Study: 29663517

Group type: EXPERIMENTAL
Intervention: Retrospective continuous glucose monitoring (CGM) (6-day sensor) at 28, 32 and 36 weeks' gestation, n = 25
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual antenatal care without CGM, n = 25
Number of subjects: 50
Study: 28064028

Group type: EXPERIMENTAL
Intervention: REAL Diabetes intervention
Number of subjects: 81

Group type: COMPARATOR
Intervention: Attention control condition
Number of subjects: 81
Study: 25719754

Group type: EXPERIMENTAL
Intervention: Trazodone (100 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 23756425

Group type: EXPERIMENTAL
Intervention: Septilin® tablets for two weeks following scaling and root planing
Number of subjects: 40

Group type: COMPARATOR
Intervention: Scaling and root planing alone
Number of subjects: 40
Study: 20058594

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg plus folic acid 0.4 mg daily (low-dose group)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg combined with folic acid 0.8 mg daily (high-dose group)
Number of subjects: 273

Group type: COMPARATOR
Intervention: Enalapril 10 mg/d alone (control)
Number of subjects: 273
Study: 17532073

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 15364767

Group type: EXPERIMENTAL
Intervention: E5531 (100 microg, 250 microg, 500 microg, or 1,000 microg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: LPS (4 ng/kg)
Number of subjects: 32
Study: 12066939

Group type: EXPERIMENTAL
Intervention: Humidified oxygen (40% mixture)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Humidified air
Number of subjects: 32
Study: 9594989

Group type: EXPERIMENTAL
Intervention: Calcium and magnesium-rich mineral water
Number of subjects: 85

Group type: COMPARATOR
Intervention: Mineral water deficient in calcium and magnesium
Number of subjects: 85

Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 85
Study: 7661123

Group type: EXPERIMENTAL
Intervention: Lutein (0.5 mumol/kg body wt)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Beta-carotene (0.5 mumol/kg body wt)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Combined doses of lutein and beta-carotene
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Lutein
Number of subjects: 8
Study: 2759842

Group type: EXPERIMENTAL
Intervention: Minimal-therapist-contact cognitive-behavioral therapy
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Clinic-based cognitive-behavioral therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 48
Study: 370527

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31366405

Group type: EXPERIMENTAL
Intervention: Silver-needle warm acupuncture
Number of subjects: 160

Group type: COMPARATOR
Intervention: Stainless steel filiform-needle warm acupuncture
Number of subjects: 160
Study: 28370730

Group type: EXPERIMENTAL
Intervention: Mind-body techniques and health-promoting lifestyle modification (7-hour once-per-week group sessions over 12 weeks)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Waiting group (no intervention)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Overall study population (after 6-month follow-up)
Number of subjects: 86
Study: 26258571

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 32
Study: 22230883

Group type: EXPERIMENTAL
Intervention: Oral leucovorin calcium (2 mg/kg per day; maximum 50 mg per day)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 93
Study: 21730977

Group type: EXPERIMENTAL
Intervention: Self-sampling of vaginal fluid (Qvintip) and HPV testing
Number of subjects: 4060

Group type: COMPARATOR
Intervention: Pap-smear screening (control)
Number of subjects: 4060
Study: 19539096

Group type: COMPARATOR
Intervention: SSRIs
Number of subjects: 18

Group type: COMPARATOR
Intervention: TCAs
Number of subjects: 18

Group type: COMPARATOR
Intervention: SNRIs (venlafaxine)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Duloxetine (SNRI)
Number of subjects: 18
Study: 17688756

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 553

Group type: COMPARATOR
Intervention: Orthopaedic specialist consultation
Number of subjects: 553
Study: 15378676

Group type: EXPERIMENTAL
Intervention: Mirtazapine (34.1 mg daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sertraline (101.5 mg daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 100
Study: 11453895

Group type: EXPERIMENTAL
Intervention: HFA-fluticasone propionate (FP) 1000 microg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: HFA-beclomethasone dipropionate (BDP) 1000 microg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: HFA-beclomethasone dipropionate (BDP) 2000 microg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: HFA-fluticasone propionate (FP) 2000 microg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9543964

Group type: EXPERIMENTAL
Intervention: Structured education program (experimental group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unstructured education program (control group)
Number of subjects: 30
Study: 7851098

Group type: EXPERIMENTAL
Intervention: Experimental condition (helped to apply for SSI)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 3
Study: 3288801

Group type: EXPERIMENTAL
Intervention: Psychorelaxation treatment (PRT) using autogenous training, biological feedback, or respiratory relaxation training techniques
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (no psychological effects and psychological placebo)
Number of subjects: 117
Study: 31200443

Group type: EXPERIMENTAL
Intervention: Personalized MICT + HIIT
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standardized MICT
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study: 28463789

Group type: EXPERIMENTAL
Intervention: Mindfulness-based program
Number of subjects: 48

Group type: COMPARATOR
Intervention: Pregnancy support program
Number of subjects: 48
Study: 25924841

Group type: EXPERIMENTAL
Intervention: Tat 30 μg given 3 times
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Tat 30 μg
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Tat 7.5 μg or 30 μg, given 3 or 5 times monthly
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Tat 30 μg, 3x
Number of subjects: 168